Yumei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yumei Wang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Lin Lu
Institute of Mental Health, Key Laboratory of Mental Health and Peking University Sixth Hospital, National Clinical Research Center for Mental Disorders, Peking University, Beijing, China
3 shared publications Nobuhiko Hoaki
Oita Univ, Fac Med, Dept Neuropsychiat, Hasamamachi, Yufu 8795593, Japan
3 shared publicationsTianle Zhang
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
3 shared publicationsTingting Xie
Institute of Brain Science and Brain-Inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shangdong, China
3 shared publicationsXiaobo Wang
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
3 shared publicationsFangming Xu
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
2 shared publications
Latest Publications
- Open Access
- 5 June 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1539038
The alteration of IL-17 signaling pathway in bipolar disorder: a preliminary study with transcriptomic perspective
Objective: Bipolar Disorder (BD) is a complex psychiatric condition influenced by genetic and environmental factors. This study aims to explore global mRNA expression in Peripheral blood white cells (PBMC) of BD patients.Methods: We analyzed whole-genome gene expression profiles from PBMC of 12 BD states-manic (BD-M), 12 BD states-depressive (BD-D), and 12 matched healthy controls (HC) using microarrays. Validation of differentially expressed genes within the IL-17 pathway was conducted through qRT-PCR, while ELISA measured specific protein levels. GO and KEGG pathway enrichment analyses were performed, alongside PPI analysis and Gene Set Variation Analysis (GSVA) to assess immune cell infiltration.Results: In the comparison between BD and HC, a total of 304 differentially expressed genes (DEGs) were identified, of which 217 genes were upregulated and 87 genes were downregulated. In the comparisons between BD and HC, BD-M and HC, and BD-D and HC, 91 DEGs were found. Enrichment analysis suggested that biological processes and signaling pathways related to extracellular matrix, stress response, heparin binding, and immune inflammation were upregulated in the BD group. KEGG analysis and PPI results indicate that the IL-17 signaling pathway plays an important role in BD and its subtypes. In the IL-17 signaling pathway, compared to HC, the expression of Jun, Fosb, Fosl1, TNFAIP3, NFKBIA, CXCL2, CXCL8, IL6 and IL17 genes was upregulated in BD patients. RT-qPCR analysis showed that the expression of Jun, Fosb, Fosl1, NFKBIA, TNFAIP3, CXCL2, and CXCL8 genes was significantly upregulated in BD, ELISA results indicated that the protein levels of CXCL8/IL-8, IL-6 and IL-17 in the BD group were significantly higher than those in the HC group (all P < 0.05). Immune infiltration analysis showed that central memory CD4+ T cells (P=0.010), eosinophils (P=0.038), and mast cells (P=0.029) were increased in infiltration in the BD group.Conclusion: This study integrates transcriptomics and immune microenvironment analysis, suggesting that the IL-17 signaling pathway may be involved in the pathogenesis of BD and its subtypes through inflammation triggered by chemokines. This research deepens our understanding of the molecular mechanisms of BD and emphasizes the importance of the immune system in its pathology.
- 5 June 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1539038
Open AccessThe alteration of IL-17 signaling pathway in bipolar disorder: a preliminary study with transcriptomic perspective
Objective: Bipolar Disorder (BD) is a complex psychiatric condition influenced by genetic and environmental factors. This study aims to explore global mRNA expression in Peripheral blood white cells (PBMC) of BD patients.Methods: We analyzed whole-genome gene expression profiles from PBMC of 12 BD states-manic (BD-M), 12 BD states-depressive (BD-D), and 12 matched healthy controls (HC) using microarrays. Validation of differentially expressed genes within the IL-17 pathway was conducted through qRT-PCR, while ELISA measured specific protein levels. GO and KEGG pathway enrichment analyses were performed, alongside PPI analysis and Gene Set Variation Analysis (GSVA) to assess immune cell infiltration.Results: In the comparison between BD and HC, a total of 304 differentially expressed genes (DEGs) were identified, of which 217 genes were upregulated and 87 genes were downregulated. In the comparisons between BD and HC, BD-M and HC, and BD-D and HC, 91 DEGs were found. Enrichment analysis suggested that biological processes and signaling pathways related to extracellular matrix, stress response, heparin binding, and immune inflammation were upregulated in the BD group. KEGG analysis and PPI results indicate that the IL-17 signaling pathway plays an important role in BD and its subtypes. In the IL-17 signaling pathway, compared to HC, the expression of Jun, Fosb, Fosl1, TNFAIP3, NFKBIA, CXCL2, CXCL8, IL6 and IL17 genes was upregulated in BD patients. RT-qPCR analysis showed that the expression of Jun, Fosb, Fosl1, NFKBIA, TNFAIP3, CXCL2, and CXCL8 genes was significantly upregulated in BD, ELISA results indicated that the protein levels of CXCL8/IL-8, IL-6 and IL-17 in the BD group were significantly higher than those in the HC group (all P < 0.05). Immune infiltration analysis showed that central memory CD4+ T cells (P=0.010), eosinophils (P=0.038), and mast cells (P=0.029) were increased in infiltration in the BD group.Conclusion: This study integrates transcriptomics and immune microenvironment analysis, suggesting that the IL-17 signaling pathway may be involved in the pathogenesis of BD and its subtypes through inflammation triggered by chemokines. This research deepens our understanding of the molecular mechanisms of BD and emphasizes the importance of the immune system in its pathology.
- Top Cited PapersOpen Access
- 3 June 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (9) , 4399-4408
Practical AI application in psychiatry: historical review and future directions
The integration of artificial intelligence (AI) in mental healthcare holds promise for enhancing diagnostic precision, treatment efficacy, and personalized care. Despite AI’s potential to analyze vast datasets and identify subtle patterns, its clinical adoption in psychiatry remains limited. This review critically examines the emerging role of AI in psychiatry, elucidating its utility, challenges, and implications for clinical practice. Through an extensive analysis of the existing literature and empirical evidence, we seek to inform psychiatric stakeholders about both opportunities and obstacles that are presented by AI. We evaluate AI’s potential to improve diagnostic accuracy, prognostic performance, and therapeutic interventions. Our pragmatic approach bridges the gap between theoretical advancements and practical implementation, providing valuable insights and actionable recommendations for psychiatric professionals. This article highlights the supportive role of AI, advocating for its judicious integration to enhance patient outcomes while maintaining the human-centric essence of psychiatric practice. By addressing these challenges and fostering collaboration, AI can significantly advance mental healthcare, reduce clinical burdens, and improve patient outcomes.
- 3 June 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (9) , 4399-4408
Top Cited PapersOpen AccessPractical AI application in psychiatry: historical review and future directions
The integration of artificial intelligence (AI) in mental healthcare holds promise for enhancing diagnostic precision, treatment efficacy, and personalized care. Despite AI’s potential to analyze vast datasets and identify subtle patterns, its clinical adoption in psychiatry remains limited. This review critically examines the emerging role of AI in psychiatry, elucidating its utility, challenges, and implications for clinical practice. Through an extensive analysis of the existing literature and empirical evidence, we seek to inform psychiatric stakeholders about both opportunities and obstacles that are presented by AI. We evaluate AI’s potential to improve diagnostic accuracy, prognostic performance, and therapeutic interventions. Our pragmatic approach bridges the gap between theoretical advancements and practical implementation, providing valuable insights and actionable recommendations for psychiatric professionals. This article highlights the supportive role of AI, advocating for its judicious integration to enhance patient outcomes while maintaining the human-centric essence of psychiatric practice. By addressing these challenges and fostering collaboration, AI can significantly advance mental healthcare, reduce clinical burdens, and improve patient outcomes.
- 8 August 2024
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 78, 101989
To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomes
- 8 August 2024
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 78, 101989
To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomes
- Open Access
- 13 March 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111816
Olink proteomics analysis uncovers inflammatory proteins in patients with different states of bipolar disorder
- 13 March 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111816
Open AccessOlink proteomics analysis uncovers inflammatory proteins in patients with different states of bipolar disorder
- Open Access
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1219151
Analysis of complete blood count and derived inflammatory indicators for bipolar disorder patients with different states
Purposes: This study aimed to analyze the predictive ability of the complete blood count and derived inflammatory indicators for BD patients with different states to identify potential biomarkers.Methods: We collected the data of BD in-patients from January 2021 to March 2023. The complete blood count and derived inflammatory indicators were computed by univariate analysis, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis.Results: In terms of BD patients, the levels of MON (pp = 0.018), and NLR (p = 0.002) were independent risk factors in logistic regression analysis, as well as the cut-off values were 0.405 109/L, 2.600 mg/L, and 2.321, respectively. Regarding BD-M patients, the levels of MON (pp = 0.012), and NLR (p = 0.002) were predictors in logistic regression analysis, and the cut-off values were, respectively, 0.505 109/L, 2.600 mg/L, and 2.620. Additionally, the levels of NLR (p = 0.006) and MHR (pp = 0.001) was related to BD-mixed and the cut-off value was 0.340 109/L. Notably, MON+hs-CRP + NLR, MON+hs-CRP + NLR, and NLR + MHR had the highest diagnostic accuracy to predict BD, BD-M, and BD-D patients, respectively.Conclusion: Our findings showed that distinct inflammatory indicators were closely associated with BD and its different states. Additionally, we also identified their cut-off values and optimal combined predictive indicators in different states of BD, helping us improve diagnostic accuracy and better assess them to manage early targeted interventions.
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1219151
Open AccessAnalysis of complete blood count and derived inflammatory indicators for bipolar disorder patients with different states
Purposes: This study aimed to analyze the predictive ability of the complete blood count and derived inflammatory indicators for BD patients with different states to identify potential biomarkers.Methods: We collected the data of BD in-patients from January 2021 to March 2023. The complete blood count and derived inflammatory indicators were computed by univariate analysis, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis.Results: In terms of BD patients, the levels of MON (pp = 0.018), and NLR (p = 0.002) were independent risk factors in logistic regression analysis, as well as the cut-off values were 0.405 109/L, 2.600 mg/L, and 2.321, respectively. Regarding BD-M patients, the levels of MON (pp = 0.012), and NLR (p = 0.002) were predictors in logistic regression analysis, and the cut-off values were, respectively, 0.505 109/L, 2.600 mg/L, and 2.620. Additionally, the levels of NLR (p = 0.006) and MHR (pp = 0.001) was related to BD-mixed and the cut-off value was 0.340 109/L. Notably, MON+hs-CRP + NLR, MON+hs-CRP + NLR, and NLR + MHR had the highest diagnostic accuracy to predict BD, BD-M, and BD-D patients, respectively.Conclusion: Our findings showed that distinct inflammatory indicators were closely associated with BD and its different states. Additionally, we also identified their cut-off values and optimal combined predictive indicators in different states of BD, helping us improve diagnostic accuracy and better assess them to manage early targeted interventions.
- Open Access
- 30 October 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (12) , 2354-2360
Perinatal exposure to earthquake stress increases the risks of hypertension and diabetes in subsequent adult life: A cross‐sectional study
The objective of the current study was to determine whether exposure to earthquake stress during pregnancy and infancy impacted on the risk of chronic adult health problems. All subjects were divided into three groups: the infant exposure group, the fetus exposure group, and the non‐exposure group. All subjects completed a standardized interview that included questions on demographic information, traumatic experiences during the earthquake, Anthropomorphic parameters such as body height, weight, and blood pressure were measured. Traumatic events in childhood and adulthood were assessed by the Childhood Trauma Questionnaire (CTQ) and Life Event Scale (LES), respectively. Totally1325 subjects were included; 399 subjects experienced the earthquake as fetuses, 374 subjects who experienced the earthquake as infants and 552 subjects did not experience the earthquake. The three groups were comparable in sociodemographic and baseline characteristics except age (Infant exposure vs Prenatal exposure vs No exposure = 39.5 ± 0.6 vs 38.5 ± 0.8 vs 37.5 ± 0.9, p < .001). Fetal and infant exposure to earthquakes was associated with elevated systolic blood pressure (both were + 3 mm Hg, p < .001). After adjustment for covariates, earthquake exposure in infants (odds ratio [OR] = 2.010, 95% confidence interval [CI] = 1.216 ~ 3.322) and fetuses (OR = 1.509, 95% CI = 1.014 ~ 2.248) was a significant and independent risk factor for hypertension. Earthquake expose in fetuses was a significant and independent risk factor for diabetes (OR = 2.307, 95% CI = 1.136 ~ 4.686). Earthquake exposure in infants and fetuses is a significant and independent risk factor for hypertension. Earthquake exposure in fetuses is significant and independent risk factor for diabetes.
- 30 October 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (12) , 2354-2360
Open AccessPerinatal exposure to earthquake stress increases the risks of hypertension and diabetes in subsequent adult life: A cross‐sectional study
The objective of the current study was to determine whether exposure to earthquake stress during pregnancy and infancy impacted on the risk of chronic adult health problems. All subjects were divided into three groups: the infant exposure group, the fetus exposure group, and the non‐exposure group. All subjects completed a standardized interview that included questions on demographic information, traumatic experiences during the earthquake, Anthropomorphic parameters such as body height, weight, and blood pressure were measured. Traumatic events in childhood and adulthood were assessed by the Childhood Trauma Questionnaire (CTQ) and Life Event Scale (LES), respectively. Totally1325 subjects were included; 399 subjects experienced the earthquake as fetuses, 374 subjects who experienced the earthquake as infants and 552 subjects did not experience the earthquake. The three groups were comparable in sociodemographic and baseline characteristics except age (Infant exposure vs Prenatal exposure vs No exposure = 39.5 ± 0.6 vs 38.5 ± 0.8 vs 37.5 ± 0.9, p < .001). Fetal and infant exposure to earthquakes was associated with elevated systolic blood pressure (both were + 3 mm Hg, p < .001). After adjustment for covariates, earthquake exposure in infants (odds ratio [OR] = 2.010, 95% confidence interval [CI] = 1.216 ~ 3.322) and fetuses (OR = 1.509, 95% CI = 1.014 ~ 2.248) was a significant and independent risk factor for hypertension. Earthquake expose in fetuses was a significant and independent risk factor for diabetes (OR = 2.307, 95% CI = 1.136 ~ 4.686). Earthquake exposure in infants and fetuses is a significant and independent risk factor for hypertension. Earthquake exposure in fetuses is significant and independent risk factor for diabetes.
- 1 March 2016
- Published by Elsevier in Sleep Medicine
- Vol. 19, 116-122
Prevalence of insomnia and its risk factors in older individuals: a community-based study in four cities of Hebei Province, China
- 1 March 2016
- Published by Elsevier in Sleep Medicine
- Vol. 19, 116-122
Prevalence of insomnia and its risk factors in older individuals: a community-based study in four cities of Hebei Province, China
- 1 December 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 142 (1-3) , 351-354
Type A behavior pattern: Bortner scale vs. Japanese-original questionnaires
- 1 December 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 142 (1-3) , 351-354
Type A behavior pattern: Bortner scale vs. Japanese-original questionnaires
- 1 January 2010
- Vol. 112 (3) , 274-9
[Reconsideration of bipolar disorder and lithium therapy].
- Open Access
- 1 January 2010
- Published by The Japanese Society of Clinical Neuropsychopharmacology in Clinical Neuropsychopharmacology and Therapeutics
- Vol. 1, 6-9
Pharmacotherapy for visual hallucinations:
- 1 January 2010
- Published by The Japanese Society of Clinical Neuropsychopharmacology in Clinical Neuropsychopharmacology and Therapeutics
- Vol. 1, 6-9
Open AccessPharmacotherapy for visual hallucinations: